Trial Profile
Fixed dose comparison of escitalopram to an active comparator in severely depressed patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Duloxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 04 Jan 2008 Status changed from in progress to completed.
- 15 Aug 2007 Status changed from recruiting to in progress.
- 19 Dec 2006 New trial record.